U.S. FDA Expands Approval for J&J HIV Drug
Mercredi 22 Octobre 2008 - 19:15 - 2 mois, 2 semaines depuis
-
Presse spécialisée
-
Medscape HIV AIDS
U.S. health regulators have expanded approval for Johnson & Johnson's Prezista in combination with other drugs to treat HIV patients who are just beginning to take medication for the virus, the company said on Wednesday. Reuters Health Information